{"transactions":[{"id":1806387,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110506,"kind":"organization","name":"MERIDIAN VENTURE PARTNERS II LP","position":1,"cik":"0001109507","reported_name":"MERIDIAN VENTURE PARTNERS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110507,"kind":"organization","name":"Meridian Venture Partners II GP, L.P.","position":2,"cik":"0001580170","reported_name":"Meridian Venture Partners II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110508,"kind":"organization","name":"Meridian Venture Partners II, Co.","position":3,"cik":"0001580169","reported_name":"Meridian Venture Partners II, Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":4,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-08-17T00:00:20.000Z","date":"2023-08-16","kind":"sale","planned":false,"acquired":false,"shares":200000,"price":58.5,"value":11700000.0,"ownership":{"direct":true},"balance_after":1819259,"source":{"system":"sec-edgar","filing":"0001104659-23-092750","document":"tm2324006-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923092750/tm2324006-1_4seq1.xml","form_type":"4"}},{"id":2098886,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110506,"kind":"organization","name":"MERIDIAN VENTURE PARTNERS II LP","position":1,"cik":"0001109507","reported_name":"MERIDIAN VENTURE PARTNERS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110507,"kind":"organization","name":"Meridian Venture Partners II GP, L.P.","position":2,"cik":"0001580170","reported_name":"Meridian Venture Partners II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110508,"kind":"organization","name":"Meridian Venture Partners II, Co.","position":3,"cik":"0001580169","reported_name":"Meridian Venture Partners II, Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":4,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-02T21:00:50.000Z","date":"2022-12-01","kind":"sale","acquired":false,"shares":200000,"price":38.5,"value":7700000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Meridian Venture Partners II, L.P. sold the shares that are the subject of this Form 4 for its liquidity purposes, and no additional sales are planned at this time."}],"balance_after":2019259,"source":{"system":"sec-edgar","filing":"0001104659-22-124079","document":"tm2231885-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465922124079/tm2231885-1_4.xml","form_type":"4"}},{"id":2288140,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":1,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-29T22:23:12.000Z","date":"2022-04-27","kind":"grant","acquired":true,"shares":10049,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in full on April 27, 2023."}],"balance_after":49021,"source":{"system":"sec-edgar","filing":"0001415889-22-004392","document":"form4-04292022_030457.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588922004392/form4-04292022_030457.xml","form_type":"4"}},{"id":2772311,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":1,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T20:36:05.000Z","date":"2021-03-23","kind":"grant","acquired":true,"shares":9292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in full on March 23, 2022."}],"balance_after":38972,"source":{"system":"sec-edgar","filing":"0001415889-21-001654","document":"form4-03252021_010352.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588921001654/form4-03252021_010352.xml","form_type":"4"}},{"id":3177394,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":1,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-14T20:34:01.000Z","date":"2020-04-10","kind":"grant","acquired":true,"shares":7119,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock vests on April 10, 2021."}],"balance_after":29680,"source":{"system":"sec-edgar","filing":"0001104659-20-046397","document":"tm2015775d6_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465920046397/tm2015775d6_form4.xml","form_type":"4"}},{"id":3430369,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110506,"kind":"organization","name":"MERIDIAN VENTURE PARTNERS II LP","position":1,"cik":"0001109507","reported_name":"MERIDIAN VENTURE PARTNERS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110507,"kind":"organization","name":"Meridian Venture Partners II GP, L.P.","position":2,"cik":"0001580170","reported_name":"Meridian Venture Partners II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110508,"kind":"organization","name":"Meridian Venture Partners II, Co.","position":3,"cik":"0001580169","reported_name":"Meridian Venture Partners II, Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":4,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-23T18:13:44.000Z","date":"2019-08-20","kind":"sale","acquired":false,"shares":5512,"price":68.18,"value":375808.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold pursuant to a Rule 10b5-1 diversification plan entered into by the Reporting Person on June 6, 2019. The shares were sold in multiple transactions at prices ranging from $68.00 to $68.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold pursuant to a Rule 10b5-1 diversification plan entered into by the Reporting Person on June 6, 2019. The shares were sold in multiple transactions at prices ranging from $68.00 to $68.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Meridian Venture Partners II, Co. (MVP Corp.) is the general partner of Meridian Venture Partners II GP, L.P. (GP), the general partner of Meridian Venture Partners II, L.P. (MVP II). Robert E. Brown, Jr., a director of the issuer, is the President, sole stockholder and sole director of MVP Corp., as well as a limited partner of GP and one of two principals of MVP II."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"This Form 4 Amendment is being filed for the sole purpose of reporting that sales under the Reporting Person's 10b5-1 diversification plan has completed, and no further sales will take place under the plan."}],"balance_after":2281283,"source":{"system":"sec-edgar","filing":"0001144204-19-041520","document":"tv528210_form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420419041520/tv528210_form4a.xml","form_type":"4/A","original_submission_date":"2019-08-21"}},{"id":3430368,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110506,"kind":"organization","name":"MERIDIAN VENTURE PARTNERS II LP","position":1,"cik":"0001109507","reported_name":"MERIDIAN VENTURE PARTNERS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110507,"kind":"organization","name":"Meridian Venture Partners II GP, L.P.","position":2,"cik":"0001580170","reported_name":"Meridian Venture Partners II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110508,"kind":"organization","name":"Meridian Venture Partners II, Co.","position":3,"cik":"0001580169","reported_name":"Meridian Venture Partners II, Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":4,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-23T18:13:44.000Z","date":"2019-08-19","kind":"sale","acquired":false,"shares":2067,"price":68.3,"value":141176.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold pursuant to a Rule 10b5-1 diversification plan entered into by the Reporting Person on June 6, 2019. The shares were sold in multiple transactions at prices ranging from $68.00 to $69.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold pursuant to a Rule 10b5-1 diversification plan entered into by the Reporting Person on June 6, 2019. The shares were sold in multiple transactions at prices ranging from $68.00 to $69.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Meridian Venture Partners II, Co. (MVP Corp.) is the general partner of Meridian Venture Partners II GP, L.P. (GP), the general partner of Meridian Venture Partners II, L.P. (MVP II). Robert E. Brown, Jr., a director of the issuer, is the President, sole stockholder and sole director of MVP Corp., as well as a limited partner of GP and one of two principals of MVP II."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"This Form 4 Amendment is being filed for the sole purpose of reporting that sales under the Reporting Person's 10b5-1 diversification plan has completed, and no further sales will take place under the plan."}],"balance_after":2286795,"source":{"system":"sec-edgar","filing":"0001144204-19-041520","document":"tv528210_form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420419041520/tv528210_form4a.xml","form_type":"4/A","original_submission_date":"2019-08-21"}},{"id":3432355,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110506,"kind":"organization","name":"MERIDIAN VENTURE PARTNERS II LP","position":1,"cik":"0001109507","reported_name":"MERIDIAN VENTURE PARTNERS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110507,"kind":"organization","name":"Meridian Venture Partners II GP, L.P.","position":2,"cik":"0001580170","reported_name":"Meridian Venture Partners II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110508,"kind":"organization","name":"Meridian Venture Partners II, Co.","position":3,"cik":"0001580169","reported_name":"Meridian Venture Partners II, Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":4,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-21T22:11:56.000Z","date":"2019-08-20","kind":"sale","acquired":false,"shares":5512,"price":68.18,"value":375808.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold pursuant to a Rule 10b5-1 diversification plan entered into by the Reporting Person on June 6, 2019. The shares were sold in multiple transactions at prices ranging from $68.00 to $68.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold pursuant to a Rule 10b5-1 diversification plan entered into by the Reporting Person on June 6, 2019. The shares were sold in multiple transactions at prices ranging from $68.00 to $68.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Meridian Venture Partners II, Co. (MVP Corp.) is the general partner of Meridian Venture Partners II GP, L.P. (GP), the general partner of Meridian Venture Partners II, L.P. (MVP II). Robert E. Brown, Jr., a director of the issuer, is the President, sole stockholder and sole director of MVP Corp., as well as a limited partner of GP and one of two principals of MVP II."}],"balance_after":2219259,"source":{"system":"sec-edgar","filing":"0001144204-19-040993","document":"tv528119_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420419040993/tv528119_form4.xml","form_type":"4"}},{"id":3432354,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110506,"kind":"organization","name":"MERIDIAN VENTURE PARTNERS II LP","position":1,"cik":"0001109507","reported_name":"MERIDIAN VENTURE PARTNERS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110507,"kind":"organization","name":"Meridian Venture Partners II GP, L.P.","position":2,"cik":"0001580170","reported_name":"Meridian Venture Partners II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110508,"kind":"organization","name":"Meridian Venture Partners II, Co.","position":3,"cik":"0001580169","reported_name":"Meridian Venture Partners II, Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":4,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-21T22:11:56.000Z","date":"2019-08-19","kind":"sale","acquired":false,"shares":2067,"price":68.3,"value":141176.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold pursuant to a Rule 10b5-1 diversification plan entered into by the Reporting Person on June 6, 2019. The shares were sold in multiple transactions at prices ranging from $68.00 to $69.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold pursuant to a Rule 10b5-1 diversification plan entered into by the Reporting Person on June 6, 2019. The shares were sold in multiple transactions at prices ranging from $68.00 to $69.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Meridian Venture Partners II, Co. (MVP Corp.) is the general partner of Meridian Venture Partners II GP, L.P. (GP), the general partner of Meridian Venture Partners II, L.P. (MVP II). Robert E. Brown, Jr., a director of the issuer, is the President, sole stockholder and sole director of MVP Corp., as well as a limited partner of GP and one of two principals of MVP II."}],"balance_after":2224771,"source":{"system":"sec-edgar","filing":"0001144204-19-040993","document":"tv528119_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420419040993/tv528119_form4.xml","form_type":"4"}},{"id":3436623,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110506,"kind":"organization","name":"MERIDIAN VENTURE PARTNERS II LP","position":1,"cik":"0001109507","reported_name":"MERIDIAN VENTURE PARTNERS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110507,"kind":"organization","name":"Meridian Venture Partners II GP, L.P.","position":2,"cik":"0001580170","reported_name":"Meridian Venture Partners II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110508,"kind":"organization","name":"Meridian Venture Partners II, Co.","position":3,"cik":"0001580169","reported_name":"Meridian Venture Partners II, Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":4,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-16T21:38:21.000Z","date":"2019-08-16","kind":"sale","acquired":false,"shares":26349,"price":68.09,"value":1794103.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold pursuant to a Rule 10b5-1 diversification plan entered into by the Reporting Person on June 6, 2019.  The shares were sold in multiple transactions at prices ranging from $68.00 to $68.52 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold pursuant to a Rule 10b5-1 diversification plan entered into by the Reporting Person on June 6, 2019.  The shares were sold in multiple transactions at prices ranging from $68.00 to $68.52 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Meridian Venture Partners II, Co. (MVP Corp.) is the general partner of Meridian Venture Partners II GP, L.P. (GP), the general partner of Meridian Venture Partners II, L.P. (MVP II). Robert E. Brown, Jr., a director of the issuer, is the President, sole stockholder and sole director of MVP Corp., as well as a limited partner of GP and one of two principals of MVP II."}],"balance_after":2226838,"source":{"system":"sec-edgar","filing":"0001144204-19-040452","document":"tv527876_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420419040452/tv527876_form4.xml","form_type":"4"}},{"id":3436622,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110506,"kind":"organization","name":"MERIDIAN VENTURE PARTNERS II LP","position":1,"cik":"0001109507","reported_name":"MERIDIAN VENTURE PARTNERS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110507,"kind":"organization","name":"Meridian Venture Partners II GP, L.P.","position":2,"cik":"0001580170","reported_name":"Meridian Venture Partners II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110508,"kind":"organization","name":"Meridian Venture Partners II, Co.","position":3,"cik":"0001580169","reported_name":"Meridian Venture Partners II, Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":4,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-16T21:38:21.000Z","date":"2019-08-15","kind":"sale","acquired":false,"shares":9315,"price":69.34,"value":645902.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold pursuant to a Rule 10b5-1 diversification plan entered into by the Reporting Person on June 6, 2019.  The shares were sold in multiple transactions at prices ranging from $68.03 to $70.53 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold pursuant to a Rule 10b5-1 diversification plan entered into by the Reporting Person on June 6, 2019.  The shares were sold in multiple transactions at prices ranging from $68.03 to $70.53 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Meridian Venture Partners II, Co. (MVP Corp.) is the general partner of Meridian Venture Partners II GP, L.P. (GP), the general partner of Meridian Venture Partners II, L.P. (MVP II). Robert E. Brown, Jr., a director of the issuer, is the President, sole stockholder and sole director of MVP Corp., as well as a limited partner of GP and one of two principals of MVP II."}],"balance_after":2253187,"source":{"system":"sec-edgar","filing":"0001144204-19-040452","document":"tv527876_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420419040452/tv527876_form4.xml","form_type":"4"}},{"id":3436621,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110506,"kind":"organization","name":"MERIDIAN VENTURE PARTNERS II LP","position":1,"cik":"0001109507","reported_name":"MERIDIAN VENTURE PARTNERS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110507,"kind":"organization","name":"Meridian Venture Partners II GP, L.P.","position":2,"cik":"0001580170","reported_name":"Meridian Venture Partners II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110508,"kind":"organization","name":"Meridian Venture Partners II, Co.","position":3,"cik":"0001580169","reported_name":"Meridian Venture Partners II, Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":4,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-16T21:38:21.000Z","date":"2019-08-14","kind":"sale","acquired":false,"shares":26360,"price":69.89,"value":1842300.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold pursuant to a Rule 10b5-1 diversification plan entered into by the Reporting Person on June 6, 2019.  The shares were sold in multiple transactions at prices ranging from $68.02 to $71.50 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold pursuant to a Rule 10b5-1 diversification plan entered into by the Reporting Person on June 6, 2019.  The shares were sold in multiple transactions at prices ranging from $68.02 to $71.50 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Meridian Venture Partners II, Co. (MVP Corp.) is the general partner of Meridian Venture Partners II GP, L.P. (GP), the general partner of Meridian Venture Partners II, L.P. (MVP II). Robert E. Brown, Jr., a director of the issuer, is the President, sole stockholder and sole director of MVP Corp., as well as a limited partner of GP and one of two principals of MVP II."}],"balance_after":2262502,"source":{"system":"sec-edgar","filing":"0001144204-19-040452","document":"tv527876_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420419040452/tv527876_form4.xml","form_type":"4"}},{"id":3440356,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110506,"kind":"organization","name":"MERIDIAN VENTURE PARTNERS II LP","position":1,"cik":"0001109507","reported_name":"MERIDIAN VENTURE PARTNERS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110507,"kind":"organization","name":"Meridian Venture Partners II GP, L.P.","position":2,"cik":"0001580170","reported_name":"Meridian Venture Partners II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110508,"kind":"organization","name":"Meridian Venture Partners II, Co.","position":3,"cik":"0001580169","reported_name":"Meridian Venture Partners II, Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":4,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-13T22:07:20.000Z","date":"2019-08-13","kind":"sale","acquired":false,"shares":20821,"price":71.77,"value":1494323.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold pursuant to a Rule 10b5-1 diversification plan entered into by the Reporting Person on June 6, 2019.  The shares were sold in multiple transactions at prices ranging from $71.15 to $73.45 per share, inclusive.  The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold pursuant to a Rule 10b5-1 diversification plan entered into by the Reporting Person on June 6, 2019.  The shares were sold in multiple transactions at prices ranging from $71.15 to $73.45 per share, inclusive.  The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Meridian Venture Partners II, Co. (MVP Corp.) is the general partner of Meridian Venture Partners II GP, L.P. (GP), the general partner of Meridian Venture Partners II, L.P. (MVP II). Robert E. Brown, Jr., a director of the issuer, is the President, sole stockholder and sole director of MVP Corp., as well as a limited partner of GP and one of two principals of MVP II."}],"balance_after":2288862,"source":{"system":"sec-edgar","filing":"0001144204-19-039648","document":"tv527471_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420419039648/tv527471_4.xml","form_type":"4"}},{"id":3440355,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110506,"kind":"organization","name":"MERIDIAN VENTURE PARTNERS II LP","position":1,"cik":"0001109507","reported_name":"MERIDIAN VENTURE PARTNERS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110507,"kind":"organization","name":"Meridian Venture Partners II GP, L.P.","position":2,"cik":"0001580170","reported_name":"Meridian Venture Partners II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110508,"kind":"organization","name":"Meridian Venture Partners II, Co.","position":3,"cik":"0001580169","reported_name":"Meridian Venture Partners II, Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":4,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-13T22:07:20.000Z","date":"2019-08-12","kind":"sale","acquired":false,"shares":21016,"price":71.45,"value":1501593.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold pursuant to a Rule 10b5-1 diversification plan entered into by the Reporting Person on June 6, 2019.  The shares were sold in multiple transactions at prices ranging from $70.25 to $72.65 per share, inclusive.  The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold pursuant to a Rule 10b5-1 diversification plan entered into by the Reporting Person on June 6, 2019.  The shares were sold in multiple transactions at prices ranging from $70.25 to $72.65 per share, inclusive.  The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Meridian Venture Partners II, Co. (MVP Corp.) is the general partner of Meridian Venture Partners II GP, L.P. (GP), the general partner of Meridian Venture Partners II, L.P. (MVP II). Robert E. Brown, Jr., a director of the issuer, is the President, sole stockholder and sole director of MVP Corp., as well as a limited partner of GP and one of two principals of MVP II."}],"balance_after":2309683,"source":{"system":"sec-edgar","filing":"0001144204-19-039648","document":"tv527471_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420419039648/tv527471_4.xml","form_type":"4"}},{"id":3440354,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110506,"kind":"organization","name":"MERIDIAN VENTURE PARTNERS II LP","position":1,"cik":"0001109507","reported_name":"MERIDIAN VENTURE PARTNERS II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110507,"kind":"organization","name":"Meridian Venture Partners II GP, L.P.","position":2,"cik":"0001580170","reported_name":"Meridian Venture Partners II GP, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110508,"kind":"organization","name":"Meridian Venture Partners II, Co.","position":3,"cik":"0001580169","reported_name":"Meridian Venture Partners II, Co.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":4,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-13T22:07:20.000Z","date":"2019-08-09","kind":"sale","acquired":false,"shares":19860,"price":71.7,"value":1423962.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold pursuant to a Rule 10b5-1 diversification plan entered into by the Reporting Person on June 6, 2019.  The shares were sold in multiple transactions at prices ranging from $70.84 to $71.78 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold pursuant to a Rule 10b5-1 diversification plan entered into by the Reporting Person on June 6, 2019.  The shares were sold in multiple transactions at prices ranging from $70.84 to $71.78 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Meridian Venture Partners II, Co. (MVP Corp.) is the general partner of Meridian Venture Partners II GP, L.P. (GP), the general partner of Meridian Venture Partners II, L.P. (MVP II). Robert E. Brown, Jr., a director of the issuer, is the President, sole stockholder and sole director of MVP Corp., as well as a limited partner of GP and one of two principals of MVP II."}],"balance_after":2330699,"source":{"system":"sec-edgar","filing":"0001144204-19-039648","document":"tv527471_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420419039648/tv527471_4.xml","form_type":"4"}},{"id":3521950,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":1,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-05-17T20:30:36.000Z","date":"2019-05-16","kind":"exercise","acquired":false,"shares":1167,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":33,"exercise_date":"2015-04-01","expiration_date":"2024-03-31","underlying":"Common Stock","underlying_shares":1167},"source":{"system":"sec-edgar","filing":"0001144204-19-027066","document":"tv521956_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420419027066/tv521956_4.xml","form_type":"4"}},{"id":3521949,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":1,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-05-17T20:30:36.000Z","date":"2019-05-16","kind":"exercise","acquired":false,"shares":1042,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":6.36,"exercise_date":"2014-07-12","expiration_date":"2023-07-11","underlying":"Common Stock","underlying_shares":1042},"source":{"system":"sec-edgar","filing":"0001144204-19-027066","document":"tv521956_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420419027066/tv521956_4.xml","form_type":"4"}},{"id":3521948,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":1,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-17T20:30:36.000Z","date":"2019-05-16","kind":"exercise","acquired":true,"shares":1167,"price":33,"value":38511.0,"ownership":{"direct":true},"balance_after":22561,"source":{"system":"sec-edgar","filing":"0001144204-19-027066","document":"tv521956_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420419027066/tv521956_4.xml","form_type":"4"}},{"id":3521947,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":1,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-17T20:30:36.000Z","date":"2019-05-16","kind":"exercise","acquired":true,"shares":1042,"price":6.36,"value":6627.12,"ownership":{"direct":true},"balance_after":21394,"source":{"system":"sec-edgar","filing":"0001144204-19-027066","document":"tv521956_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420419027066/tv521956_4.xml","form_type":"4"}},{"id":3572725,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":1,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-04-01T20:01:02.000Z","date":"2019-03-28","kind":"grant","acquired":true,"shares":3127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The restricted stock and stock options vest on March 28, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock and stock options vest on March 28, 2020."}],"balance_after":3127,"derivative":{"exercise_price":66.39,"expiration_date":"2029-03-27","underlying":"Common Stock","underlying_shares":3127},"source":{"system":"sec-edgar","filing":"0001144204-19-017405","document":"tv517657_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420419017405/tv517657_4.xml","form_type":"4"}},{"id":3572724,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":1,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-01T20:01:02.000Z","date":"2019-03-28","kind":"grant","acquired":true,"shares":2584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The restricted stock and stock options vest on March 28, 2020."}],"balance_after":20352,"source":{"system":"sec-edgar","filing":"0001144204-19-017405","document":"tv517657_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420419017405/tv517657_4.xml","form_type":"4"}},{"id":3900486,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":1,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2018-06-08T20:01:14.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":2575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The restricted stock and stock options vest on May 17, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock and stock options vest on May 17, 2019."}],"balance_after":2575,"derivative":{"exercise_price":65.86,"expiration_date":"2028-06-05","underlying":"Common Stock","underlying_shares":2575},"source":{"system":"sec-edgar","filing":"0001144204-18-033524","document":"tv496172_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420418033524/tv496172_4.xml","form_type":"4"}},{"id":3900485,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":1,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T20:01:14.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":1200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The restricted stock and stock options vest on May 17, 2019."}],"balance_after":17768,"source":{"system":"sec-edgar","filing":"0001144204-18-033524","document":"tv496172_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420418033524/tv496172_4.xml","form_type":"4"}},{"id":4362429,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":1,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-04-04T22:07:24.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":3250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The restricted stock and stock options vest on the first anniversary of the grant date."}],"balance_after":3250,"derivative":{"exercise_price":49.51,"exercise_date":"2017-03-31","expiration_date":"2027-03-30","underlying":"Common Stock","underlying_shares":3250},"source":{"system":"sec-edgar","filing":"0001144204-17-018958","document":"v463550_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420417018958/v463550_form4.xml","form_type":"4"}},{"id":4362428,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":1,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-04T22:07:24.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The restricted stock and stock options vest on the first anniversary of the grant date."}],"balance_after":16568,"source":{"system":"sec-edgar","filing":"0001144204-17-018958","document":"v463550_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420417018958/v463550_form4.xml","form_type":"4"}},{"id":4553393,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":1,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase","published_at":"2016-11-16T21:21:17.000Z","date":"2016-11-15","kind":"exercise","acquired":false,"shares":2333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person acquired the shares reported in Table I via a cash exercise of the options reported in Table II."}],"balance_after":1167,"derivative":{"exercise_price":33,"exercise_date":"2014-04-01","expiration_date":"2024-03-31","underlying":"Common Stock","underlying_shares":2333},"source":{"system":"sec-edgar","filing":"0001144204-16-134966","document":"v453281_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420416134966/v453281_form4.xml","form_type":"4"}},{"id":4553392,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":1,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase","published_at":"2016-11-16T21:21:17.000Z","date":"2016-11-15","kind":"exercise","acquired":false,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person acquired the shares reported in Table I via a cash exercise of the options reported in Table II."}],"balance_after":1042,"derivative":{"exercise_price":6.36,"exercise_date":"2013-07-12","expiration_date":"2023-07-11","underlying":"Common Stock","underlying_shares":3125},"source":{"system":"sec-edgar","filing":"0001144204-16-134966","document":"v453281_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420416134966/v453281_form4.xml","form_type":"4"}},{"id":4553391,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":1,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-16T21:21:17.000Z","date":"2016-11-15","kind":"exercise","acquired":true,"shares":2333,"price":33,"value":76989.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired the shares reported in Table I via a cash exercise of the options reported in Table II."}],"balance_after":15568,"source":{"system":"sec-edgar","filing":"0001144204-16-134966","document":"v453281_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420416134966/v453281_form4.xml","form_type":"4"}},{"id":4553390,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":110509,"kind":"person","name":"Brown Robert E. JR","position":1,"cik":"0001579672","reported_name":"Brown Robert E. JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-16T21:21:17.000Z","date":"2016-11-15","kind":"exercise","acquired":true,"shares":3125,"price":6.36,"value":19875.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired the shares reported in Table I via a cash exercise of the options reported in Table II."}],"balance_after":13235,"source":{"system":"sec-edgar","filing":"0001144204-16-134966","document":"v453281_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420416134966/v453281_form4.xml","form_type":"4"}}]}